These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 28396675)
1. Inactivation of the β(1,2)-xylosyltransferase and the α(1,3)-fucosyltransferase genes in Mercx S; Smargiasso N; Chaumont F; De Pauw E; Boutry M; Navarre C Front Plant Sci; 2017; 8():403. PubMed ID: 28396675 [TBL] [Abstract][Full Text] [Related]
2. Multiplexed, targeted gene editing in Nicotiana benthamiana for glyco-engineering and monoclonal antibody production. Li J; Stoddard TJ; Demorest ZL; Lavoie PO; Luo S; Clasen BM; Cedrone F; Ray EE; Coffman AP; Daulhac A; Yabandith A; Retterath AJ; Mathis L; Voytas DF; D'Aoust MA; Zhang F Plant Biotechnol J; 2016 Feb; 14(2):533-42. PubMed ID: 26011187 [TBL] [Abstract][Full Text] [Related]
3. Engineering the Göritzer K; Grandits M; Grünwald-Gruber C; Figl R; Mercx S; Navarre C; Ma JK; Teh AY Front Plant Sci; 2022; 13():1003065. PubMed ID: 36161010 [TBL] [Abstract][Full Text] [Related]
4. Inactivation of Herman X; Far J; Courtoy A; Bouhon L; Quinton L; De Pauw E; Chaumont F; Navarre C Front Plant Sci; 2021; 12():634023. PubMed ID: 33584780 [No Abstract] [Full Text] [Related]
5. Establishment of a tobacco BY2 cell line devoid of plant-specific xylose and fucose as a platform for the production of biotherapeutic proteins. Hanania U; Ariel T; Tekoah Y; Fux L; Sheva M; Gubbay Y; Weiss M; Oz D; Azulay Y; Turbovski A; Forster Y; Shaaltiel Y Plant Biotechnol J; 2017 Sep; 15(9):1120-1129. PubMed ID: 28160363 [TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9-mediated knockout of six glycosyltransferase genes in Nicotiana benthamiana for the production of recombinant proteins lacking β-1,2-xylose and core α-1,3-fucose. Jansing J; Sack M; Augustine SM; Fischer R; Bortesi L Plant Biotechnol J; 2019 Feb; 17(2):350-361. PubMed ID: 29969180 [TBL] [Abstract][Full Text] [Related]
7. Inactivation of the β (1, 2)-xylosyltransferase and the α (1, 3)-fucosyltransferase gene in rice (Oryza sativa) by multiplex CRISPR/Cas9 strategy. Jung JW; Shin JH; Lee WK; Begum H; Min CH; Jang MH; Oh HB; Yang MS; Kim SR Plant Cell Rep; 2021 Jun; 40(6):1025-1035. PubMed ID: 33547931 [TBL] [Abstract][Full Text] [Related]
8. Production of recombinant human granulocyte macrophage-colony stimulating factor in rice cell suspension culture with a human-like N-glycan structure. Shin YJ; Chong YJ; Yang MS; Kwon TH Plant Biotechnol J; 2011 Dec; 9(9):1109-19. PubMed ID: 21801300 [TBL] [Abstract][Full Text] [Related]
9. Silencing β1,2-xylosyltransferase in Transgenic Tomato Fruits Reveals xylose as Constitutive Component of Ige-Binding Epitopes. Paulus KE; Mahler V; Pabst M; Kogel KH; Altmann F; Sonnewald U Front Plant Sci; 2011; 2():42. PubMed ID: 22639593 [TBL] [Abstract][Full Text] [Related]
10. Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Strasser R; Stadlmann J; Schähs M; Stiegler G; Quendler H; Mach L; Glössl J; Weterings K; Pabst M; Steinkellner H Plant Biotechnol J; 2008 May; 6(4):392-402. PubMed ID: 18346095 [TBL] [Abstract][Full Text] [Related]
11. Deletion of plant-specific sugar residues in plant N-glycans by repression of GDP-D-mannose 4,6-dehydratase and β-1,2-xylosyltransferase genes. Matsuo K; Kagaya U; Itchoda N; Tabayashi N; Matsumura T J Biosci Bioeng; 2014 Oct; 118(4):448-54. PubMed ID: 24794851 [TBL] [Abstract][Full Text] [Related]
12. Sequential Genome Editing and Induced Excision of the Transgene in Sheva M; Hanania U; Ariel T; Turbovski A; Rathod VKR; Oz D; Tekoah Y; Shaaltiel Y Front Plant Sci; 2020; 11():607174. PubMed ID: 33324440 [TBL] [Abstract][Full Text] [Related]
13. Generation of Arabidopsis thaliana plants with complex N-glycans lacking beta1,2-linked xylose and core alpha1,3-linked fucose. Strasser R; Altmann F; Mach L; Glössl J; Steinkellner H FEBS Lett; 2004 Mar; 561(1-3):132-6. PubMed ID: 15013764 [TBL] [Abstract][Full Text] [Related]
14. Generation of glyco-engineered BY2 cell lines with decreased expression of plant-specific glycoepitopes. Yin BJ; Gao T; Zheng NY; Li Y; Tang SY; Liang LM; Xie Q Protein Cell; 2011 Jan; 2(1):41-7. PubMed ID: 21337008 [TBL] [Abstract][Full Text] [Related]
15. Gene Inactivation by CRISPR-Cas9 in Nicotiana tabacum BY-2 Suspension Cells. Mercx S; Tollet J; Magy B; Navarre C; Boutry M Front Plant Sci; 2016; 7():40. PubMed ID: 26870061 [TBL] [Abstract][Full Text] [Related]
16. A genome-edited N. benthamiana line for industrial-scale production of recombinant glycoproteins with targeted N-glycosylation. Kogelmann B; Melnik S; Bogner M; Kallolimath S; Stöger E; Sun L; Strasser R; D'Aoust MA; Lavoie PO; Saxena P; Gach JS; Steinkellner H Biotechnol J; 2024 Jan; 19(1):e2300323. PubMed ID: 37804142 [TBL] [Abstract][Full Text] [Related]
17. Reduced immunogenicity of Arabidopsis hgl1 mutant N-glycans caused by altered accessibility of xylose and core fucose epitopes. Kaulfürst-Soboll H; Rips S; Koiwa H; Kajiura H; Fujiyama K; von Schaewen A J Biol Chem; 2011 Jul; 286(26):22955-64. PubMed ID: 21478158 [TBL] [Abstract][Full Text] [Related]
18. Expression of rat beta(1,4)-N-acetylglucosaminyltransferase III in Nicotiana tabacum remodels the plant-specific N-glycosylation. Frey AD; Karg SR; Kallio PT Plant Biotechnol J; 2009 Jan; 7(1):33-48. PubMed ID: 18778316 [TBL] [Abstract][Full Text] [Related]
19. The "humanized" N-glycosylation pathway in CRISPR/Cas9-edited Nicotiana benthamiana significantly enhances the immunogenicity of a S/preS1 Hepatitis B Virus antigen and the virus-neutralizing antibody response in vaccinated mice. Pantazica AM; van Eerde A; Dobrica MO; Caras I; Ionescu I; Costache A; Tucureanu C; Steen H; Lazar C; Heldal I; Haugslien S; Onu A; Stavaru C; Branza-Nichita N; Liu Clarke J Plant Biotechnol J; 2023 Jun; 21(6):1176-1190. PubMed ID: 36779605 [TBL] [Abstract][Full Text] [Related]
20. Production of different glycosylation variants of the tumour-targeting mAb H10 in Nicotiana benthamiana: influence on expression yield and antibody degradation. Lombardi R; Donini M; Villani ME; Brunetti P; Fujiyama K; Kajiura H; Paul M; Ma JK; Benvenuto E Transgenic Res; 2012 Oct; 21(5):1005-21. PubMed ID: 22238065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]